Are there serum levels of MMP-2 and MMP-9 may be markers of COPD phenotypes? Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Progression of monocrotaline-induced pulmonary hypertension in rats can be monitored by plasma activity of matrix metalloproteinase-2 and plasma levels of tenascin-C and proBNP Source: Eur Respir J 2007; 30: Suppl. 51, 7s Year: 2007
Elevated serum S100A4 levels in patients with silicosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019
Elevated circulating adiponectin levels in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
Increased concentration of matrix metalloproteinase-9 in serum of COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 54s Year: 2005
Serum levels of STR-3 and TIMP-2 in lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002
Increased expression of MMP-2 in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity Source: Eur Respir J 2005; 26: Suppl. 49, 21s Year: 2005
High serum levels of YKL-40 in IPF Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
Increased EMMPRIN and MT1-MMP levels in the plasma of the stable adult patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 404s Year: 2005
Leptin and adiponectin levels in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011
Circulating endothelin-1 levels in patients with COPD Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009
Serum 1,25(OH)2D levels and arterial hypertension (AH) in sarcoidosis patients Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009
VEGF serum levels in COPD patients without pulmonary hypertension – a case control study Source: International Congress 2018 – Biomarkers of COPD Year: 2018
Decrease in circulating monocyte metalloproteinase-9 content with increasing severity of pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 5s Year: 2002
MMP-9 and TIMP-1 expression in acute lung injury rats with diabetes Source: Eur Respir J 2004; 24: Suppl. 48, 557s Year: 2004
The relationship between serum MMP-9 concentration and arterial blood oxygenation in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 20s Year: 2007
Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005
Age related alterations in sputum and plasma MMP-9 and TIMP-1 levels in healthy non-smokers and smokers Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010
Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients Source: Eur Respir J 2005; 25: 885-890 Year: 2005